Related Experiment Video
Updated: Aug 5, 2026

08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Proteome-wide target profiling of α-helix mimetics
Amrita Date1, Archie Wall1, Hannah Kiely-Collins1
1Department of Chemistry, Molecular Sciences Research Hub, Imperial College London 82 Wood Lane London W12 0BZ UK a.barnard@imperial.ac.uk.
RSC Chemical Biology
|July 30, 2026
Summary
Targeting protein-protein interactions (PPIs) is difficult. This study compares three α-helix mimetic scaffolds, revealing distinct proteome-wide selectivity differences for these promising small molecule drug candidates.
Area of Science:
- Medicinal Chemistry
- Chemical Biology
- Drug Discovery
Background:
- Protein-protein interactions (PPIs) are crucial in disease but challenging drug targets due to large, featureless interfaces.
- α-helix mimetics offer a strategy to target helix-mediated PPIs by mimicking key residues.
- Existing scaffolds lack comprehensive proteome-wide selectivity data.
Purpose of the Study:
- To directly compare the proteome-wide selectivity of three distinct α-helix mimetic scaffolds.
- To evaluate the potential of small molecule scaffolds in targeting helix-mediated protein-protein interactions.
- To identify differences in target engagement across diverse chemical classes.
Main Methods:
- Affinity-based protein profiling was employed.
- Three classes of α-helix mimetics were analyzed: N-substituted oligobenzamides, pyrrolopyrimidines, and oxopiperazines.
- Proteome-wide binding was assessed for each scaffold.
Main Results:
- Significant differences in proteome-wide selectivity were observed among the three α-helix mimetic classes.
- Each scaffold exhibited a unique binding profile across the proteome.
- This cross-comparison provides novel insights into scaffold-specific targeting.
Conclusions:
- The choice of α-helix mimetic scaffold significantly impacts proteome-wide selectivity.
- Understanding these selectivity differences is crucial for rational drug design targeting PPIs.
- Further exploration of these scaffolds can lead to more selective therapeutics.

